Reckitt Consumer Health Growth Helps Fuel Pharma Unit Divestment Buzz
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser says it will focus on its consumer health business, led by the Mucinex OTC decongestant line, and other core units with strong sales and will review its slumping Rx business, including considering a sale.